medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (3)


Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity

O’Connor K, Walsh JC, Schaeffer DF

Idioma: Ingles.
Referencias bibliográficas: 25
Paginas: 317-322
Archivo PDF: 155.77 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985; 55: 124-35.

  2. Theise ND, Nakashima O, Park YN, Nakanuma Y. Combined hepatocellular-cholangiocarcinoma. Bosman FT, Carneiro F, Hruban RH, Theise ND (ed.). WHO classification of tumours of the digestive system. Lyon, France: IARC Press; 2010, p. 225-7.

  3. Wachtel MS, Zhang Y, Xu T, Chiriva-Internati M, Frezza EE. Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol 2008; 1: 43-7.

  4. Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, Boyle P, Storm H. Cancer incidence in five continents. Lyon France: IARC Press; 2007.

  5. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular- cholangiocarcinoma: a clinicopathologic study. J Gastroenterol Hepatol 1998; 13: 34-40.

  6. Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003; 33: 283-7.

  7. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical and prognostic factors. Cancer 2002; 94: 2040-6.

  8. Komuta M, Spee B, Vander Borght S, DeRos R, Verslype C, Aerts R, Yano H, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008; 47: 1544-56.

  9. Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, Fukusato T et al. Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol 2000; 31: 1011-7.

  10. Imai Y, Oda H, Arai M, Shimizu S, Nakatsuru Y, Inoue T, Ishikowa T. Mutational analysis of the p53 and K-ras Genes and Allelotype Study of the Rb-1 Gene for investigating the Pathogenesis of Combined Hepatocellular-Cholangio-cellular Carcinomas. Jpn J Cancer Res 1996; 87: 1056-62.

  11. Kassahun WT, Hauss J. Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 2008; 62: 1271-8.

  12. Fowler KJ, Sheybani A, Parker RA 3rd, Doherty SM, Brunt E, Chapman WC, Menias CO. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 2013; 201: 332-9.

  13. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular- cholangiocarcinoma. Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res 2005; 32: 185-95.

  14. Fukukura Y, Taguchi J, Nakashima O, Wada Y, Kojiro M. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J Comput Assist Tomogr 1997; 21: 52-8.

  15. Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, Blumgart LH, et al. Combined hepatocel-lular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol 2002; 26: 989-97.

  16. Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol 2013; 26: 782-91.

  17. Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, Park YN. Primary liver carcinoma of intermediate (hepatocytecholangiocyte) phenotype. J Hepatol 2004; 40: 298-304.

  18. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25: 3818-22.

  19. Theise ND, Yao JL, Harada K, Hytiroglou P, Portmann B, Thung SN, Tsui W, et al. Hepatic ‘stem cell’ malignancies in adults: four cases. Histopathology 2003; 43: 263-71.

  20. Lee JH, Chung G, Yu S, Hwang SY, Kim JS, Kim HY, Yoon JH, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 2011; 45: 69-75.

  21. Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 2012; 19: 2869-76.

  22. Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transplant 2011; 17: 934-42.

  23. Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest 2013; 123: 1911-8.

  24. Chi M, Mikhitarian K, Shi C, Goff LW. Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer 2012; 5: 199- 202.

  25. Kim GM, Jeung HC, Kim D, Kim JH, Yoon SH, Jung ES, Shin SJ. A case of combined hepatocellular-cholangiocarcinoma with favourable response to systemic chemotherapy. Cancer Res Treat 2010; 42: 235-8.




2020     |     www.medigraphic.com